SOX2 and laryngeal carcinoma: Previous reports have shown that C-myc (Tian et al., 2018), Oct-4 (El Deeb & Abdelzaher, 2014), Nanog and Sox-2, as biomarkers of CSCs, have not been reported to be associated with laryngeal cancer.